BioSpace News Archive

Bioanalysis is a branch of analytical chemistry that deals with biological samples for analysis of measurement of biological molecules, DNA, large molecules, and others.

MRM Health announced that they have received regulatory approval from the Federal Agency for Medicines and Health Products in Belgium to start a Phase 1b/2a trial with the novel next-generation optimized consortium therapy, MH002, in patients with mild-to-moderate ulcerative colitis.

Tiziana Life Sciences plc announces that it has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman has a beneficial interest, purchased 100,000 ordinary shares of 3p each in the market at a price of 52p per share.

Merck, known as MSD outside the United States and Canada, will hold its third-quarter 2021 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Thursday, October 28.

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi as shareholders, announced that the U.S. Food and Drug Administration has accepted and granted Priority Review for a New Drug Application for investigational, injectable cabotegravir long-acting for pre-exposure prophylaxis, or PrEP.

TScan Therapeutics, Inc. announced that David Southwell, President and Chief Executive Officer, will participate in a virtual fireside chat at the Chardan 5th Annual Genetic Medicines Conference on Tuesday, October 5, 2021 at 2:00 p.m. ET.

One in two American children under six years of age tested have detectable levels of lead, a toxic metal, in their blood, according to a new Health Trends® study from Quest Diagnostics released and published in JAMA Pediatrics.

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the supplemental Biologics License Application (sBLA) for PD-1 inhibitor Libtayo ®

Athersys, Inc. (NASDAQ: ATHX) announced today that a Conference is being held Oct. 12th to 14th, 2021 in Carlsbad

SAB Biotherapeutics today announced the appointment of Russell Beyer as chief financial officer (CFO), effective September 20, 2021.